MILLENNIUM MANAGEMENT LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$62,845,003
+11.6%
4,062,379
+13.3%
0.03%
+10.7%
Q2 2023$56,322,958
+78648.0%
3,585,166
-17.4%
0.03%
-31.7%
Q1 2023$71,523
+104.8%
4,339,982
+93.9%
0.04%
+115.8%
Q4 2022$34,919
-99.7%
2,238,381
+124.1%
0.02%
+137.5%
Q3 2022$12,957,000
-25.8%
998,999
-19.7%
0.01%
-27.3%
Q2 2022$17,458,000
+80.3%
1,243,422
+83.9%
0.01%
+120.0%
Q1 2022$9,682,000
+1484.6%
676,131
+1407.5%
0.01%
Q4 2021$611,000
+137.7%
44,851
+186.2%
0.00%
Q3 2021$257,000
-93.8%
15,669
-93.6%
0.00%
-100.0%
Q2 2021$4,139,000
-31.0%
245,912
-25.1%
0.00%
-25.0%
Q1 2021$5,997,000
-34.8%
328,449
-36.3%
0.00%
-63.6%
Q3 2020$9,195,000
-41.3%
515,404
-41.0%
0.01%
-47.6%
Q2 2020$15,669,000
+13.4%
873,923
-4.0%
0.02%
-32.3%
Q1 2020$13,817,000
+107.6%
910,211
+169.9%
0.03%
+287.5%
Q4 2019$6,654,000
+100.5%
337,271
+79.9%
0.01%
+60.0%
Q2 2019$3,319,000
-91.6%
187,487
-90.3%
0.01%
-91.5%
Q1 2019$39,502,000
+18273.0%
1,939,209
+15050.1%
0.06%
Q4 2018$215,00012,8000.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders